Heredity Cancer

Prevention is better than cure. Early Prediction and detection of cancer maximize patient health outcomes and decrease a person’s risk of developing certain types of cancer.
At Novo Genomics, we test for hereditary genetic variants that increase the chances of a person developing cancer during their lifetime.
Our comprehensive cancer genetic test covers hereditary blood cancers, hereditary leukemia, hereditary breast cancer, and gynecological cancers, hereditary colorectal cancers, hereditary endocrine tumor syndromes, hereditary gastrointestinal cancers, hereditary lung cancers, hereditary melanoma and skin cancers, hereditary pancreatic cancers, hereditary renal cancers, neurofibromatosis, tuberous sclerosis, and xeroderma pigmentosum